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Abstract

Introduction

A model is presented visualizing the events leading
to calcium-salt, crystal- and stone-formation inside the
nephron. For each nephron segment, handling of urine
components relevant to stone formation is considered
and urine composition determined. This information
was applied to nucleation experiments simulating passage
of urine through a nephron. The model and in vitro experiments suggest that within normal transit times for the
respective nephron segments, particles of a hydroxyapatite-like material first form near the bend in the Loop of
Henle of juxtamedullary nephrons. From there on, calcium oxalate particles start to appear: first dihydrate,
then monohydrate. In the collecting duct system, particle size increases primarily due to crystal agglomeration.
Several conclusions with clinical and experimental relevance can be drawn. An increase in urinary volume
does not decrease the chance of crystal formation in the
Loop of Henle, but does decrease passage time through
the collecting ducts, and thus, the time allowed for large
particle formation. A calcium load does not increase the
risk for nucleation up to the distal tubule, but does increase the risk of large particle formation in the collecting ducts. An oxalate load increases the chance for nucleation throughout the nephron. For experiments simulating crystalliz.ation processes occurring inside the nephron, diluted urines should be used. They should be
diluted 16 to 50 times for testing nucleation, 2 to 30
times for testing crystal growth, and 2 to 20 times for
testing crystal agglomeration. Undiluted urines may be
used to mimic conditions in the pelvis and the bladder.

Crystalluria, the formation of particles which flow
freely with the urine, is common for most people.
However, formation of a particle which is not excreted
freely, urolithiasis, occurs only in 5 to 9% of the population. Theoretically, and as seen in animal experiments, the step from a free particle to a stone probably
involves particle retention (20, 31, 35, 36]. This may
be a fixed particle mechanism, fixation of particles to
the nephron wall or trapping in sites with poor flow-conditions, a free particle mechanism, formation of particles
too large to be excreted freely, or a combination. Ideally , the fixed particle mechanism is preferred up to the
late distal tubule. However, under hyperoxaluric conditions, a free particle mechanism seems to occur in the
proximal tubule (31] . In the collecting ducts and the
duct of Bellini, both a fixed and a free particle mechanism are likely [35]. The chances for the latter are especially increased by the size increasing process known
as crystal agglomeration [35]. A role for crystal agglomeration in stone formation has been subscribed by experimental data. Urine contains numerous compounds
capable of effecting crystal agglomeration [ 17, 25, 38,
60] . The ability of urine to inhibit crystal agglomeration
is decreased in stone formers (19, 37, 40]. This may be
due to a low citrate excretion (19, 27, 37, 40], or aberrant action of urinary proteins like crystal matrix protein
(60], Tamm-Horsfall protein (THP) and nephrocalcin
(NC) [22, 26, 58].
A problem with these in vitro data is that the test
conditions may not reflect the conditions at the site of
stone formation. But, what are those conditions? It
appears obvious that crystalliz.ation experiments should
be performed using whole, undiluted urine. However,
whole undiluted urine is such a strong inhibitor of crystalliz.ation processes that for crystalliz.ation to take place,
usually extra calcium or oxalate has to be added [50,
54]. This makes one wonder how any crystals could
ever form in urine. Then, there is the phenomenon of
patients who comply very well to their drinking advice
and produce high volume urines. Often, these urines
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Table 1. A distinction is made between superficial and
juxtamedullar nephrons. The latter have a larger glomerulus diameter, longer LH with a thin segment, different resorption characteristics, and in humans, constitute 14% of the nephrons. The values are compared to
micropuncture data [54], which usually describe the
proximal tubule and distal tubule of superficial nephrons
and the LH of juxtamedullary nephrons. Conditions in
the proximal and distal tubule of juxtamedullary nephrons and the LH of superficial nephrons must be assessed by extrapolation.

have saturation levels so low that nucleation occurs only
after very prolonged times or not at all. Still, these
patients may continue forming stones.
The answer to these questions may lie in the kidney
function. A kidney daily concentrates a large pool of
filtered plasma to a relatively small volume of urine, in
the process, removing and adding compounds which play
a role in stone formation. During its passage through
the nephron, the composition of the urine continuously
changes and differs greatly from that of the pelvic urine.
Further addition of compounds and cellular debris in the
pelvis and bladder complete the final composition. In
this paper, I try to model the changing conditions along
the nephron and relate these to the chance of particle and
stone formation inside the nephron. For most parameters relevant to urolithiasis, these changes under normal
physiologic conditions per nephron segment are well described or can be assessed reasonably. The parameters
included here are calcium, oxalate, citrate, phosphate,
uric acid, sodium, potassium, chloride, magnesium, NC,
pH, THP and volume. The following questions are addressed: where is crystallization most likely to start;
what are the roles of calcium phosphate and calcium oxalate crystallization and of kidney anatomy; where and
how do alkali-therapy, protein-, calcium- or oxalaterestriction, and drinking advice influence the risk for
stone formation; what is the most realistic way for testing urine samples: in vitro, undiluted or diluted?

Volwne
Per minute, 125 ml serum is filtered , yielding 58
ml/min filtrate per kidney and a total of 167 1/24 hr.
Volume is reduced by reabsorption of water in three
compartments of the nephron: the proximal tubule, the
DLH and the CD to the daily urine volume of 0.6 to 7 .5
liters (0.2 to 2.6 ml/min per kidney). During short time
periods, flows up to 5.8 ml/min can be sustained. The
fine regulation related to dietary load occurs mainly in
the CD. Micropuncture studies in superficial nephrons
show that 35 % of the filtered load leaves the proximal
tubule and 20% enters the distal tubule [9, 54] . Thus,
15 % is resorbed in the SDLH. In juxtamedullary nephrons, the TF /P inulin ratio at the bend of the LH at the
papillary tip averages 1: 11. 3, with extremes up to
1:18.1. Thus, volume is reduced to between 9 and 5%
[21 , 29, 42]. When the proximal tubule of juxtamedullary and superficial nephrons act alike, 65 % resorption,
then the LDLH resorbs 26 to 30% of the filtered load.
These numbers probably are underestimates of the true
concentrating capacity. In micropuncture experiments,
exposure of the papilla results in a loss in concentrating
capacity of up to 57% [44, 53, 57], probably because
urea can no longer diffuse from the pelvic urine to the
medullary interstitium, diminishing the effectivity of the
countercurrent mechanism. Resorption up to the CD is
fairly independent of the diuresis state, depending mainly
on glomerular filtration rate. Regulation from the 5 to
20 %, leaving the distal tubule to the daily end volume,
occurs in the CD (Table 1).

Abbreviations Used and Nephron Segmentation
The nephron is subdivided into proximal tubule;
Loop of Henle (LH): descending (DLH) and ascending
(ALH), short and long (SDLH, LDLH, SALH and
LALH); distal tubule (without connecting tubule segment, CNT); outer and inner medullary collecting duct
(OMCD and IMCD); duct of Bellini, and collecting duct
system (CD, consisting of CNT + OMCD + IMCD +
DOB). Abbreviations used are: TF/P and TF/UF, concentration ratios of tubular fluid to plasma and plasma
ultrafiltrate respectively; THP, Tamm-Horsfall protein;
NC, nephrocalcin; COM, calcium oxalate monohydrate;
HAP, hydroxyapatite; UA, uric acid. The distal tubule
referred to in micropuncture studies includes the CNT,
which differs in properties from the true distal tubule,
especially in its capacity to resorb water. Here, the
CNT is included in the CD.

Calciwn, sodiwn, magnesiwn, chloride
The normal values for UFNa• UFc 1, UFca and
UFMg are 145 mM, 122 mM, 1.45 mM and 0.53 mM.
The 24-hr excretion ranges (mmoles) I used are 50 to
400 Na, 50 to 400 Cl, 0.5 to 22 Ca and 0.5 to 10 Mg.
Dietary loading with these compounds does not affect
filtered load, but is regulated in the distal tubule and
first part of the CD. In superficial nephrons in rodents,
at the end of the proximal tubule, TF /UFNa averages
1.03, TF/UFc 8 1.2, TF/UFMg 1.8 [1, 15, 43, 45, 48,
62]. In the SDLH, no resorption of Na and Ca occurs.
In the LDLH, volume is reduced 4 to 7 times compared

Data Used
Concentration limits and conditions per nephron-segment are calculated using limit-values for 24-hour excretion, plasma and ultrafiltrate concentrations and percent
resorption/excretion per segment, mostly from ref. [9],
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Table 1. Concentration and excretion ranges in plasma (mM), ultrafiltrate (mM) and 24-hr urine (mmoles, low and
high end of the ranges), own data and [9, 54).
Vol,!

Ca

ox.103

PO 4

Na

K

0.5-50

0 .4-2

136-145

3 .6-4.8

o.5-5o*2

0.48-2.4

136-145

Plasma

--

1.58-5

Ultrafilt.

-

1.02-

< 3*l

UA

cit

0 .6-1.2

0.17-0.30

0.087-0 .147

3.6-4.8

0.45-1.00

0 .17-0.30

0.087-0 .147

Mg

24-hr, low

0 .6

0.5

100

5

45

20

0.5

2

0.1

24-hr, high

7.5

7.5

2000

75

582

260

12.5

10

7.5

•t At high plasma calcium concentrations the ultrafiltrability decreases due to the formation of calcium phosphate nuclei

in the plasma.
* 2With normal renal function a plasma oxalate concentration of 10 µM is the maximum, with impaired renal function

in hereditary hyperoxaluria, values up to 50 µM can be found.

---------------------------------------------------------------------------------·--LALH is thus calculated as (length short loop) I (length
long loop) times resorption in short loops: (18/6) * 27 =
81 %.

to the end proximal tubule. Thus, TF /UFNa should
reach 4.12 to 7.21. Measured TF/UFNa values at the
bend of long LH, however, average 2.2 to 2.6 [13, 29),
with extremes up to 6 [13). It appears that 35% of the
NaCl load entering the LDLH (12 % of the filtered load)
is reabsorbed in the upper portion of the DLH [61) .
Micropunctures of LDLH before the bend showed
an average calcium concentration of 3 mM [28). In
light of the accompanying TF/P inulin values of 6.63, a
calcium concentration of 4.1 mM would be expected.
Thus ± 1 mM was reabsorbed, presumably in the upper
portion of the LDLH. The maximum calcium concentration, when no further reabsorption occurs in the thin
segment, will be 5 .1 to 8.1 mM in loops where the
TF IP inulin reaches 11. 3 to 18. Comparable estimates
of calcium concentrations are obtained when I assume
that calcium and sodium are handled similarly. When
35 % of the load entering the LDLH is reabsorbed, concentrations reach 4.6 to 8.05 mM. Reabsorption of Na,
K, Mg, Ca and Cl in the ALH occur with equal efficiency, mainly in the thick part. In superficial nephrons, TF/P values for Na, K, Mg, and Ca reach 0.5, 5,
0.6 and 0.5 respectively at the early distal tubule and
0.2, 0.2, 0.3 and 0.2 at the late distal tubule [2, 54).
For juxtamedullary nephrons, these numbers are assumed here to be the same or higher.

Phosphate
UFro 4 averages 3.4 mM, ranging up to 4.7 mM.
Below the reabsorption threshold, TF /Pro4 falls to 0. 7
in the proximal tubule [54), 75% reabsorption, 10% is
reabsorbed in the distal tubule and 3 to 7 % in the CD
f23, 24, 521. Above the threshold, increases in filtered
load are excreted quantitatively.
Oxalate

Plasma oxalate concentration in humans averages 2

µM and varies with loading. In hyperoxaluric patients
with normal renal function, a basal value of 5 µM is
found . With impaired renal function, levels may reach
50 µM [65). Oxalate reabsorption and secretion seems
to occur in the proximal tubule. No clear quantitation is
available for this. I assume all oxalate enters the nephron at the glomerulus. This affects the validity of the
model for extreme situations where nucleation occurs in
the proximal tubule. Upon dietary loads, the excretion
in controls increases up to 290 % over fasting values,
from 0.011 to 0.033 mmole/hr [5]. When 167/24 =
6.96 liters of plasma is filtered per hour, this corresponds to plasma oxalate concentrations of 1.58 and 4.6
µM. Stone formers reportedly reacted twice as strongly
to acute loads, plasma oxalate values reaching 5 times
the reported fasting value of 1.6 µM [5].

Potassium

UFK is 3.6 mM. The regulation of Kand Na differs especially in the LDLH. There, K is secreted, restoring it to approximately the filtered load. The K concentration in the LDLH is assumed to approach that in
SALH as the urine enters the distal tubule. The amount
of potassium entering the distal tubule is increased to the
final pelvic urine value by active secretion. The resorption occurring in juxtamedullary LALH is not known.
It is assumed here that the resorption process itself is
equally efficient in short and LALH. The resorption in

Uric acid

Uric acid is reabsorbed and secreted in the proximal
tubule; 7 to 12 % reaches the final urine, determined by
the daily purine load [9].

pH
Micropuncture data from superficial nephrons shows
that pH is lowered from 7 .4 in the plasma to 6 . 7 in the
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Table 2. Conditions employed in nucleation experiment to simulate parameters at the end of a given nephron segment.
The end values for DOB are based on high normal values for calcium and oxalate and a urine volume of one liter.

Ca
mM

ox

PO 4

Na

Cl

Mg

mM

mM

mM

mM

mM

CIT
mM

6.7

1.35

0.009

1.35

151.5

154.7

0.99

0.03

40

7.26

7.9

0.05

8

408.7

423.8

4

0.2

6.85

100

6.65

1.35

0.05

8

158.7

153.9

0.59

0.2

16

22.85

31

6.38

0.75

0.05

3.2

48.9

47.1

0.3

0.2

7.15

30

50

6.16

7.5

0.5

42

199

175

5

2

added
ml

total
ml

time
sec

pH

PROX

0.5

0.5

0

LDLH

0.5

1

LALH

5.85

DISTAL
Duct of
Bellini

proximal tubule, and is 6. 7 in the early distal tubule.
When the urine is concentrated by water resorption in
the DLR, the concentrations of CO 2 and bicarbonate increase. Some CO 2 diffuses to the interstitium, resulting
in an increased pH. In the LDLH, pH is increased to
7.4. For the SDLH, no data is available. However,
when I assume the increase is related to the concentrating efficiency, which is two times lower in the SDLH,
pH will reach 7 .1 to 7 .2. The pH is brought to its endvalue in the distal tubule and CD.

ment, the crystal growth and crystal agglomeration parameters are calculated using a complete description of
COM-crystallization kinetics as described extensively
previously [6, 8, 64]. The solubility {(VLc in mM),
where Le is the solubility product based on concentrations}, growth inhibition(% G.I.), and agglomeration
inhibition {(tm)/(tm)c) of COM-crystals are measured as
three separate, system-independent parameters. The
latter two are relative to a control experiment. The
urines were tested undiluted.

Relative supersaturation (RS)

Undiluted urines

The RS for COM, UA, brushite and HAP is calculated using EQUIL [63], adapted with values for activity
constants and COM-solubility determined in our laboratory [7, 34].

Undiluted urines were made under-saturated, required for measuring solubility, by dialyzing overnight
against chelex, a cation chelating column material. This
removes all Ca and Mg. Magnesium is restored to its
original concentration and the solubility is measured.
The removal of tracer ions has no effect on the solubility
[34]. For the kinetic experiment, untreated undiluted
urine was used directly or with 1.2 mM oxalate added.

Nephrocalcin (NC), Tamm-Horsfall protein (THP)
The production site for NC is unknown. lmmunohistochemically, it can be found in the proximal and distal tubule. I assume the average daily excretion, 1.9
µmoles, originates half from each site and that NC is not
reabsorbed in the nephron. THP is localized in the
ALH and early distal tubule. The total amount present
is assumed to increase from zero entering the ALH to
the average 24-hr value of 0.5 µmoles at the middle of
the distal tubule.

Measurement of the nucleation lag-time

The nucleation lag-time(,) was measured according
to [3]. Supersaturated solutions were prepared by mixing a cation and an anion buffer into a polystyrene cuvette. The cation buffer contains calcium, magnesium,
sodium, potassium and chloride. The anion buffer contains urate, chloride, phosphate, citrate, oxalate, sodium
and optionally bicarbonate. The compositions of the
buffers are chosen such that in the mixture concentrations, ionic strength and pH resemble those around the
bend of a LH. For a short loop, the concentrations
were as follows: 2.99 mM Ca, 4.5 mM or 16 mM PO4 ,
0.01 mM oxalate, 252 mM Na, 21 mM K, 2.26 mM
Mg, 0.132 mM urate, 0.08 mM citrate, pH 7.19, 7.20
and 7.21 and Cl as rest ion. For a long LH, the concentrations used were: 7. 9 mM Ca, 8 mM phosphate,
0.05 mM oxalate, 408. 7 mM Na, 80 mM K, 4 mM Mg,
0.432 mM urate, 0.331 mM citrate, pH 7.29 and Cl as

Crystalli:iation experiments

The effects of urine on COM-crystallization kinetics
are determined with a well-established seeded crystal
growth system in which uptake of 45 Ca by aged and pregrown crystals is measured [6, 8, 64). Two types of experiments are performed. In the first, the starting supersaturation is constant but growth time is varied. In the
second, growth time is constant, while the starting calcium oxalate concentration product is varied around the
expected solubility. Solubility is then measured as the
lowest concentration product after which uptake of 45 ca
due to crystal growth occurs. From the kinetic experi474
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Figures 1 (at left) and 2 (at right). Changes in total volume per nephron segment for four 24-hr urine volumes (Fig.
1) and the relative dilution per segment as compared to the final total volume (Fig. 2): 0.6 (squares), 1 (diamonds),
2 (circles) and 7.5 liters (triangles).
rest ion. In some experiments, 47 mM bicarbonate was
added. There, urate had to be left out. When simulating the conditions around the bend of the LH, it is assumed that the changes occurring in the descending and
ascending limb are linear. Thus, the change per unit
length is obtained by dividing the total change by the
length of the limb. For instance, when the amount of
water resorbed in the D LH is put at 100 %, 7 5 % is assumed to be resorbed, when 75 % of the distance to the
bend has been traversed.
The OD590 (optical density measured at 590 nm) is
measured during ten minutes in a spectrophotometer.
When particles are formed, an apparent absorption occurs due to particle-induced light scattering. The onset
of this absorption is taken to be r. Actually, this will
slightly overestimate the real value. After 5 or 10 minutes, a sample was filtered over 0.05 µm Nucleopore filters. The filters were then gold-coated and analyzed using a 525 M Philips (Eindhoven, Netherlands) scanning
electron microscope (SEM) operated at 15 kV.

represent what is present in the proximal tubule. A 0.01
ml sample is taken at time z.ero and filtered immediately
over 0.05 µm nucleopore filters. Then, buffers are
added gradually until at time = 40 seconds the conditions resemble those present at the bend of a long LH.
A sample is taken at 40 seconds, and new buffers are
added, working towards the conditions present at the end
of the ALH. This process takes 100 seconds. Then, a
sample is taken at 140 seconds (100 + 40) and new
buffers are added, etc. Total addition time is 221 seconds. After this, no more buffers were added . The solution was kept mixed and samples were taken at 240,
300 and 600 seconds. The solution is kept at a fixed
stirring rate in a double-walled round-bottom vessel at
37°C. The buffers are added at opposite vessel-sides,
using multi-channel peristaltic U202 Whatson Marlow
(Falmouth, Cornwall, U.K.) pumps. The filters were
gold-coated and analyzed using SEM.

Nephron nucleation system

Total volume and dilution factor

The conditions in the nephron change continuously.
The precipitation processes occurring under these changing conditions were tested in the dynamic nucleation
system. In this nucleation system, the composition of
the experiment is changed continuously (Table 2) by
adding a series of different buffers. At time z.ero, 0.25
ml of an anionic and cationic buffer are combined under
rapid mixing. The starting conditions in the mixture

The total volume per nephron segment decreases,
moving from the glomerulus to the pelvic area (Fig. 1).
Four examples were used representing low, 0.6 l; average, 1 and 2 l; and high 24-hr volumes, 7.5 l. For in
vitro experiments, it can be seen that relative to the 24hr volume, urine needs to be diluted 2 to 20 times to
simulate conditions in the CD, where agglomeration may
be most important [35], and 16 to 50 times to simulate

Results
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Ut

Table 3. Standard dilution for in vitro experiments.
24-hr
vol.
0.5

1
1.5

Dilution
OMCD

Dilution
IMCD

21.4
10.9
7.4

5.4
3. 2
2.4
2.0
1.6
1.3

2

5.6

3
5

3.9
2.5

30 ~ - - - - - - - - - - - - ~

20

0 -----,--~,---~,----!

0

20

40

60

80

t (min)

3

Figures 3, 4 and 5 at right.
Figure 3. Seeded crystal growth experiment using
whole undiluted urine directly (squares) or with 1.2 mM
oxalate added (circles) . Hollow and filled symbols represent two consecutive experiments with the same urine.
Ut is the fractional uptake of calcium into the crystal
mass.

300--.--------------~
□

200

Figure 4. Nucleation lag-times (squares) in solutions
representing the conditions around the bend of a long
Loop of Henle. On the x-axis is given how far the point
is removed from the bend, depicted as 0. The units are
% of the DLH on the left side of the bend and % of the
ALH on the right side of the bend. The diamonds represent the surplus time, the transit time from the point of
measurement to the end of the LALH minus the lag-time
at that point. When the surplus time is positive, there is
sufficient time for nucleation to occur.
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Figure 5. Increasing doses of phosphocitrate were added to solutions representing the situation at the tip of a
long Loop of Henle (Table 2, but with 10 mM PO4 , diamonds) , phosphocitrate was added in increasing doses at
different pH-values: 0.5 µM (circles), 2.5 µM (triangles), 5 µM (crossed squares), 25 µM (crossed circle).
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conditions in the DLH and ALH, where nucleation may
occur first (Fig. 2). The dilution factor in the CD depends on the end volume (Table 3). In the distal tubule,
urine flow is fairly constant: 5.8 ml/min per kidney or
16. 7 liters per day [35] . Concentration to the final
volume takes place in the OMCD and IMCD. The following formulae are obtained assuming resorption occurs
evenly over the total length of both segments 16 mm
(OMCD) and 6 mm (IMCD) [35]: volume removed
equals: 16.7 - 24-hrvolume; volume at midpoint OMCD
equals: 16.7 - (16 .7 - x)(22/8); volume at junction
OMCD/IMCD equals: 16. 7 - (16. 7 - x)(22/16); volume
at midpoint IMCD equals: 16. 7 - (16. 7 - x)(19/22). Of
this concentration, approximately two-thirds occurs in
the OMCD and one-third in the IMCD. Thus, the urine
should be diluted in the above-mentioned manner.
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Table 4. TF/UF-values at end of each segment.

.UF Proximal

SDLH

LDLH

SALH

LALH

sup. distal

juxt. distal

CD

1

0.35

0.20

0.05-0.09

0.20

0.05-0.09

0.20

0.05-0.09

0.004-0.045

VOL

1

1.22

2.1

3.2-5.6

0.52

0.52

0.21-0.52

0.21-0.52

0.07-21

Ca

1

3.5

5

11-20

5

11-20

5

11-20

250

ox

1

0.75-1.2

1.3-2.1

2.9-8.4

0. 75-2.1

0.75-8.4

0.5-2.1

0.5-8.4

0.5-90

PO4

1

1.03

1.8

2.2-6

0.5

0.5

0.2

0.2

0.04-6.7

Na

1

1.1

5

10-20

5

10-20

0.2

0.2

0.6-100

K

1

1.8

3.1

7-12.6

0.55

0.55

0.21-0.55

0.21-0.55

0.07-21

Mg

1

0.2-0.4

0.35-0.7

0.8-2.8

0.35-0.7 0.8-2.8

0.35-0.7

0.8-2.8

0.8-40

UA

1

0.06-0.85

0.1-1.4

0.2-6

0.1-1.4

0.2-1.4

0.1-1.4

0.2-6

0.4-83

CIT

7.25 6.7

7.1

7.4

6.7

6.7

*

*

0

0

0

0

50

50

0

0

0

THP

0

50

0

0

50

50

0

0

0

NC

-

pH

*The regulation of pH to its end-value occurs in the distal tubule [9].

-------------------------------------------------------------------------------------------Table 4 shows the changes along the nephron for
Ca, Na, Mg, oxalate, PO4 , K, UA, citrate, pH, NC and
THP. High normal values for Ca- and oxalate 24-hr
excretion and a 24-hr volume of 2 liters were used.

creases from 7 .19 to 7 .22. During the lag-time period,
pH did not change. When low doses of phosphocitrate
were added to solutions representing the bend of a long
LH (Table 2, LDLH with 10 mM PO4), r increased
greatly (Fig. 5).

Crystal growth and agglomeration

Nephron nucleation

In undiluted urine, measurable 45 Ca-uptake occurred
only after addition of 1.2 mmoles/liter oxalate (Fig. 3).

Samples were taken at 40, 140, 171, 221, 240, 300
and 600 seconds and analyzed using a SEM. At 40 seconds, rounded particles, that are 0.7 µm in diameter, are
found, mainly as aggregates up to 6 µm large (Fig. 6).
By infrared analysis, the material was characterized as
HAP. After 140 seconds, representing the end of the
LALH, single COD-crystals, 2 µm, and agglomerates,
up to 4.4 µm, start to appear. At 171 seconds, leaving
the distal tubule, both COD and COM can be found. At
221 seconds, agglomerates up to 7 µm, and after 600
seconds, large, 15-30 µm, COM-agglomerates and COM
rosettes are found (Fig. 7).

Concentrations

Nucleation lag-times
In Figure 4, T is shown for solutions simulating the
conditions around the bend of a long LH (Table 2).
Coming from the end proximal tubule conditions, where
concentrations approach 75 % of those at the bend of the
LH, r falls within the remaining passage time of urine
through the loop, 140 seconds for the total loop [35].
When the solution is diluted from the bend-conditions to
early distal tubule conditions, r increases strongly after
40 % of the ALH has been traversed. The precipitate is
a HAP-like material. Addition of bicarbonate further
decreases r, suggesting a carbonate-containing type of
HAP. When conditions in a short LH are simulated
(2.99 mM Ca, 4.5 mM PO4 , pH 7.2), T exceeds 300
seconds. With 2.99 mM Ca, 16 mM PO4, pH 7.2 (high
phosphate load), Tis 40 seconds. The lag-time is very
dependent on the pH, decreasing 8-fold when pH in-

Discussion
Crystal formation is an essential first step in stone
formation. However, while crystalluria is common in
both healthy subjects and stone formers [18, 46, 55], the
step from a harmless free flowing crystal to formation of
a stone occurs in only 5 to 9 % of the population. A
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Figure 6. A scanning electron micrograph of the material which precipitates in the conditions existing at the tip of a
long Loop of Henle as described in Table 2. By infrared analysis, the material was shown to be HAP. Bar = 10 µ.m.

------------------------------------------------------------------------------------particle causes harm when it's size approaches the dimensions of the urinary tract it is passing through or
when it adheres to the cell linings, free and fixed particle mechanism respectively [20, 35]. Important factors
in this respect are: processes increasing particle size
(crystal growth and agglomeration), stickiness of particles and cell lining, architecture of the kidney, the site
of nucleation, and transit time through the kidney . Previously, we have shown which retention mechanisms
play a role in specific parts of the nephron [35] and how
crystal agglomeration poses a risk factor in urolithiasis
[19, 35, 36, 37, 40] . Remaining questions were: do 24hr urine samples mimic the actual situation at the site of
stone formation; where does nucleation start in the nephron; where do dietary factors and commonly used therapies intervene? Here, I modeled the chances of crystal
formation per nephron segment and their dependence on
factors such as diet and medical therapy. The literature
data used for this model are obtained from micropuncture studies using dog, rat and rabbit. These data cannot
be extrapolated directly to the human situation, which
should be kept in mind while evaluating the model. To

increase the validity of the model, ranges of concentrations etc. were used which may comprise those occurring in humans.
It is clear from the model that under normal conditions, no crystal formation occurs in the proximal tubule. Total volume is reduced by 65 %, but stone components are removed too. As a result, the urine generally remains too dilute. Crystal formation in the proximal
tubule occurs only with a high oxalate or uric acid
filtered load, as witnessed in animal studies [31]. Moving into the LH, a distinction must be made between superficial and juxtamedullary nephrons. In the first,
urine is concentrated to 20% of the filtered load. Formation of crystals occurs only with moderate increases
in phosphate load or strong increases in oxalate or uric
acid load, and at pH values over 7 .20. At the bend of
the LDLH, however, urines are concentrated much
more, to 5-9 % of the filtered load and pH reaches 7.4.
It was shown previously that under the conditions existing at the bend of the LDLH, an apatite-like material is
found after 1 hour [14]. I have confirmed here that a
HAP-like material, probably containing carbonate, is
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Figure 7. A scanning electron micrograph of the crystal material present in the nephron nucleation system after 600
seconds. Bar = 10 µm.

formed under conditions routinely present in the LH of
juxtamedullary nephrons. The nucleation lag-times fall
well within the passage time through the long LH. The
sizes of single particles (0.7 µm) and agglomerates (6
µm) formed are small relative to the inner diameter of
the ALH (19-29 JLm). However, the experiments were
performed under relatively high shear forces . In vivo,
these forces may be smaller, allowing for larger agglomerates to be formed. It was concluded before [47] that
while calcium-phosphate is nucleated in the LH, calcium
oxalate nucleation is more likely to occur in the later
parts of the nephron. For calcium oxalate nucleation to
occur within the time-frame of the loop passage (140
seconds), a relative supersaturation of 28 is required [3] .
The calcium concentration in a specific loop is relatively
constant in time, depending mainly on the resorption-efficiency of that loop. When, in my calculations, I take
a range of possible calcium concentrations in different
loops (2, 4, 6 or 8 mM), the oxalate values needed for
a RS of 28 are 0.39, 0.195, 0.13 or 0.097 mM. For a
short loop, concentrating 5 times, 390 and 195 µM oxalate loop-concentrations correspond to plasma values of

78 and 39 µM. For long loops concentrating 11.1
times, loop concentrations of 130 and 97 µM correspond
to plasma oxalate values of 11. 7 and 8.7 µM. For long
loops concentrating 20 times, a loop concentration of 97
JLM corresponds to a plasma value of 4.9 µM .
Thus, in juxtamedullary nephrons, HAP nucleation
may occur routinely. This is also seen in in vivo experiments in rat models of nephrolithiasis, where calcium
phosphate crystals preferentially deposit at the LR/proximal tubule junction [30, 49] and calcium oxalate nucleation occurs when plasma oxalate exceeds 5 JLM . Normal
fasting plasma oxalate concentrations (2 µM) are insufficient. Upon acute oxalate dietary loads, the urinary oxalate excretion rate in normal controls increases up to
290%, from 0.011 to 0.033 mmole per hour [5]. Assuming that 167/24 = 6.96 liters of plasma is filtered
per hour, this corresponds to plasma values of 1.58 and
4.6 µM . Stone formers are reported to react stronger to
acute loads, with maximum plasma oxalate values reaching 5 times the fasting value [11]. With a fasting
plasma oxalate of 2, this would imply a peak plasma
value of 10 µM. In hereditary hyperoxaluria, fasting
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gle particles are approximately one-tenth the size of the
inner diameter of the segments they are passing through.
However, within the transit time from the nucleationsite, the bend of the LH, to the end of the Duct of Bellini, 181 seconds under low diuresis, larger COM-agglomerates are formed in the collecting duct conditions.
Kidney architecture favors agglomeration to take place
in the CD, where crystals originating from some 4000
nephrons meet in one collecting duct. The agglomerates
will include organic material [32] and the process will be
influenced by compounds not included here like THP
and NC. These events occur already at high normal calcium, phosphate and oxalate excretion rates of 7.5, 42
and 0.5 mmoles/24 hr respectively and a total volume of
one liter. Under more extreme acute loading conditions,
concentration of oxalate may increase two-fold, and that
of phosphate four-fold, in the LH. Precipitation then
also may occur in the superficial nephrons, further enhancing the chance of big particle formation in the collecting ducts.
A distinction between two types of nephrons also
occurs in animal studies where mild crystalluria is induced using 0. 75 % ethylene glycol and 2 % ammonium
chloride. There, crystals are found in a restricted
number of collecting ducts [31, 35]. It is not known
whether this stems from differences in the type of nephrons discharging into the collecting ducts.
The model and experimental data lead to several
simple but surprising conclusions. The first concerns
the question as to how urine should be tested in in vitro
crystallization experiments. Usually, it is assumed that
using untreated and undiluted urine mimics the situation
at the site of stone formation . Surprisingly, when undiluted urines are tested, it is seen that crystallization
proceeds at an extremely low rate. Only when urine
was ultrafiltered, removing high molecular weight compounds, diluted, or when extra oxalate was added did
appreciable crystallization occur. If undiluted whole
urine is representative for the site of stone formation, it
is hard to imagine how crystals, let alone even large particles, could ever form. From the model, it follows that
using undiluted urine actually simulates events in the
bladder and the pelvic area. The situation inside the
nephron is much different. From the site where nucleation starts, the DLH, the following events (relevant for
stone formation) occur: water is reabsorbed, causing
concentration of compounds which are not reabsorbed,
such as NC, oxalate and citrate; calcium may be reabsorbed and pH reduced, and proteins like THP enter the
solution. Thus, if you want to mimic the situation inside
the nephron, you need to add water and calcium, increase pH, etc. For testing crystal agglomeration and
growth occurring in the OMCD, IMCD and duct of Bellini, the collected urine should be tested at 1: 2 to 1: 20

plasma oxalate values approach 5 µM. Nucleation requirements may be met under acute oxalate loading in
normals and more likely in stone formers. In hyperoxaluria, calcium oxalate nucleation in the LH or earlier
seems inevitable. In the most severe conditions, hereditary hyperoxaluria with renal impairment, plasma oxalate values may reach 50 µM and calcium oxalate crystals are found at the end proximal tubule already. The
same is seen in rat studies where oxalate excretion is increased 6 times by administration of oxalate or ethylene
glycol [35] . In these severe cases, calcium oxalate crystals are found also in other organs like the skeleton.
This would imply that calcium oxalate nuclei circulate in
the plasma. However, since the crystals are not found
in the early proximal tubule, it is more likely that the
nucleation is locally triggered.
Thus, thermodynamically, nucleation is likely to
occur in the LDLH within the required time-frame.
However, nucleation kinetics may be affected by other
means. Nucleation lag-time can be decreased by membranous material [33] or crystal matrix protein [59] or
increased by inhibitors like citrate, magnesium and NC
[4]. However, when all low molecular weight compounds were included at the concentrations occurring in
the LDLH, nucleation lag-times were still within transit
times. NC was not included. NC can decrease the rate
of secondary calcium oxalate nucleation by 42 % at a
concentration of 0.2 µM [4]. The concentration of NC
in the LDLH will be between 0.016 and 0.097 µM, thus
below its effective concentration range. The lag-time
for HAP nucleation in the LDLH is below 3 seconds,
compared to a transit time of 140 seconds for the total
loop. As was shown here with phosphocitrate, low concentrations of effective inhibitors could delay nucleation
long enough to allow safe passage of the LH. Theoretically, such compounds can postpone the nucleation risk
to the late distal tubule and collecting duct system.
The sizes of particles formed up to the distal tubule
seem too small to allow a free particle mechanism. Retention in the LH would require adherence to the cell
lining. In this respect, it will be interesting to investigate if the presence of a compound like THP [41] or
crystal matrix protein [60] in the coat of tubular cells in
the ALH interferes with crystal-cell adhesion. Downstream through the ALH and further, conditions become
less favorable for HAP crystallization and calcium oxalate crystals appear. Interestingly, in the in vitro experiments, the amount of HAP material seems to diminish.
THP now enters the urine and may interfere with calcium oxalate nucleation together with compounds like NC.
The HAP nuclei may thereby act as heterogeneous nucleators for calcium oxalate [16]. First, COD is found,
then also rosettes and agglomerates of platelet-like
COM. Up to the conditions simulating the CD, the sin480
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eration. Also, phosphate excretion is increased [37],
causing increased supersaturation with HAP in the LH.
When an animal protein load is combined with an increased sodium chloride intake, the increased ionic
strength in the collecting ducts provides an additional
factor for promoting THP self-aggregation and increasing crystal agglomeration. This may explain the exaggerated decrease in crystal agglomeration inhibition
found in urines of persons receiving a combined protein
salt load [39].
A special case of acidification effects is posed by
renal tubular acidosis (RTA). Normally, with acid loading, the decrease in pH distally acts to decrease the
propensity for HAP crystallization. With RTA, the decrease in citrate is not compensated by a decrease in pH;
consequently, CaP crystallization is more likely to continue in the distal tubule and further on.
Thiazide treatment increases calcium reabsorption in
the distal tubule. Thus, this will not affect the chances
of nucleation in the LH. The reduced calcium in the
distal tubule and CD does, however, decrease the rate of
crystallization there and diminishes the propensity for
THP self-aggregation.
Also interesting are the effects of water loading.
The concentrations in the proximal tubule and DLR are
relatively independent of the hydration state of the body.
In the CD, however, a water load will strongly increase
the urine flow and decrease the possibility of large particle retention by increased shear forces and decreased
residence time. Additionally, the higher dilution decreases the propensity for THP self-aggregation and
crystal agglomeration.
The model also points to what value urine parameters actually have. Citrate and oxalate values give information on chances for crystallization throughout the
nephron. Measuring urine volume is relevant for what
happens in the collecting ducts, pelvis and bladder. The
interpretation of urine calcium values depends on the
source of the calcium, hypercalcemia or dietary loading.
Measuring crystal growth and crystal agglomeration effects in undiluted urine bears relevance to the pelvic and
bladder situation. Measuring these parameters, using
urines diluted between 1:2 to 1:9 times, is relevant for
describing the events in the IMCD and duct of Bellini,
where in vivo agglomeration probably plays its biggest
role.
The model also points to the relevance of some
structural kidney features. When retention occurs in the
LH or distal tubule, the main mechanism seems to be
fixation of crystals to the cells lining the segments.
Interesting in this respect is that THP and NC, which
are thought to play a role in stone formation, are produced by cells at these sites. Tamm-Horsfall protein is
expressed on the membrane in the ALH and the early

dilutions after addition of up to 5 times the 24-hr amount
of calcium and at pH values higher than the 24-hr urine
pH. For testing nucleation and crystal growth in the
ALH and distal tubule, urine should be diluted to a value
of 16.7 to 33.4 l. For testing nucleation occurring in
the DLR, urine must be diluted to a volume of 16. 7 to
58.5 l, after removal of THP and other compounds entering the urine after the proximal tubule.
The clinical use of the model lies in visualizing the
effects of specific conditions and (therapeutic) actions.
A high Ca-load, with relative constant serum Ca, does
not influence the calcium concentrations nor the chances
for nucleation up to the distal tubule. Conditions involving an increased serum-Ca do increase the chances of
nucleation in the LH. A load of oxalate or PO4 directly
increases the chance for nucleation. An increase in filtered oxalate occurring after ingestion of food with a
high oxalate content, like chocolate [5], almost triples
the RS with COM. This will cause formation of calcium oxalate crystals to occur earlier in the nephron. In
extreme cases, induced in rat studies, calcium oxalate
crystals are found in the proximal tubule already [35].
A load with uric acid will increase the likelihood of
sodium urate formation in the LH and ofUA crystallization further in the nephron. The effects of an acid load
are more complicated. Acid loading causes an increased
citrate resorption proximally. Since citrate acts as an
inhibitor of calcium salt nucleation, this decrease in
concentration increases the chance of apatite and calcium
oxalate nucleation in the LH. In the distal tubule and
further on, calcium reabsorption is decreased and acidification increased. On one band, this lowers the rate of
HAP crystallization, counteracting the effect of a lower
citrate. On the other hand, conditions of lower pH,
lower citrate concentration and higher calcium concentration, increase the self-aggregation of THP [27]. This
decreases the ability of the urine to inhibit crystal agglomeration [19, 27]. Obviously, alkali loading, asapplied to the treatment of calcium oxalate urolithiasis
[51], bas the reverse effects. It decreases the likelihood
of HAP crystallization in the LR, due to the increased
citrate excretion. In the distal tubule and further, the
effect on HAP crystallization of an increased citrate concentration is counteracted by an increased pH. The
main beneficial effect of alkali therapy may be the
changed conditions in the CD, higher citrate, and higher
pH, which increase the inhibition of crystal agglomeration at that site [19, 27, 34].
Even more complicated are the effects of a high intake of animal protein. An animal protein load increases
calcium excretion [10, 56] and acts as an acid load [39],
with the same negative effects. In addition, it will cause
an increase in uric acid excretion [12], which further increases the likelihood of nucleation and crystal agglom481
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(eds.). Plenum Press, New York. pp. 355-357.
[12] Coe FL, Moran E , Kavalich AG (1976) The
contribution of dietary purine overconsumption to hyperuricosuria in calcium oxalate stone formers. J Chron Dis
29: 793-800.
[13] de Rouffignac C, Morel F (1969) Micropuncture study of water, electrolytes and urea movement
along the Loops of Henle in Psammomys. J Clio Inv 48:
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[14] Deganello S, Asplin J , Coe FL (1990) Evidence that tubule fluid in the thin segment of the Loop
of Henle normally is supersaturated and forms a poorly
crystallized hydroxy-apatite that can initiate renal stones.
Kidney Int 37: 472 (abstract).
[15] Duarte CG, Watson JF (1967) Calcium reabsorption in proximal tubule of the dog nephron. Am J
Physiol 212: 1355-1360.
[16] Ebrahimpour A, Perez L , Nancollas GH (1991)
Induced crystal growth of calcium oxalate monohydrate
at hydroxyapatite surfaces. The influence of human
serum albumin, citrate and magnesium. Langmuir 7:
577-583.
[17] Edyvane KA, Hibberd CM, Hamett RM,
Marshall VR, Ryall RL (1987) Macromolecules inhibit
calcium oxalate crystal growth and aggregation in whole
urine. Clin chim Acta 167: 329-338.
[18] Elliott JS, Rabinowitz IN (1976) Calcium

parts of the distal tubule, and is thought to form a water
impermeable layer. This property might also play a role
in repelling crystals. Changes in the density or the
structure of membrane-bound THP might contribute to
increase.d adherence.
Another structural feature which plays a role is the
natural-occurring variety in length of the LH. The
length can vary from 33 to 140 mm. When the length
of the loop increases, two risk factors increase as well .
First, the urinary saturation with calcium salts increases
with increasing loop-length. This is somewhat counteracted by the increasing ionic strength. However, especially in the LDLH, sodium chloride is also resorbed.
Second, the passage time of the urine and the particles
formed in it increases because of both the increase.d
length and the reduced volume, thus reduced flow of
urine. The presence of more, longer loops and conditions where preferentially more long loops are used
might thus be considered risk factors for nephrolithiasis.
In the development of human kidneys, growth continues
until adulthood, mainly due to elongation of the proximal tubule and LH. This continuous increase in long
loops may be relevant to the finding that the incidence
of stone formation before adulthood is low and reaches
its peak in the second decade of life.
Concluding, the model presented here may help investigators by clearly defining the conditions occurring
at the site of nephrolithiasis.
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Discussion with Reviewers

S.R. Khan: Nucleation experiments were carried out in
inorganic solutions without the proteins which are generally present in the urine. Do you think calcium phosphate will crystallize in the presence of these proteins in
the Loop of Henle?
Author: At the tip of the Loop of Henle, one may expect membranous material, crystal matrix protein (urinary prothrombin fragment 1), nephrocalcin and proteins
I am not aware of. In the discussion, I have pointed out
that the concentration of nephrocalcin in the Loop of
Henle will be at least 2 to 10 times below the concentration needed to decrease the rate of nucleation by 42 %.
Actually, at the tip of the Loop of Henle, the induction
time is less then 3 seconds compared to the transit time
through the ascending limb of the Loop of Henle of 100
seconds. The nucleation rate would need to be decreased more then 95 % to completely prevent nucleation. I have no assessment on the concentrations of
crystal matrix protein and membranous material at the
site, nor about how the balance of counteractive actions
would be.

S.R. Khan: Renal papillary surface epithelium may
also be involved in urine concentration. What will be its
effect on urolithiasis?
Author: Given the high flow rate through the Duct of
Bellini, I am not convinced that changes in urinary concentration can play a dominant role there. This may be
different when you consider that the ducts may be closed
at times at those sites. I do not know how to fit this into
the model. Finally, I see a role for damaged epithelium,
where the chance of particle adhesion may be increased.

J.P. Kavanagh: How well can one make quantitative
estimates for average human nephrons from measurements using individual animal nephrons?
Author: As mentioned in the text, extrapolating the animal data to the human situation poses a potential error.
For the sake of the model, however, I feel that when the
precaution is taken to use ranges of values including the
extreme low and high values, in most cases, the "human• situation will be included.

J.P. Kavanagh: Using average data may tell us something about the normal possibility of nucleation events in
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different nephron segments, but it may be important to
consider the nucleation behaviour at all extremes of anatomical and excretory patterns. Lack of nucleation in
average nephrons does not necessarily mean its absence
in all, and one burst of nucleation may be sufficient to
initiate a stone.
Author: This is completely true. For this reason, I
explicitly dealt with the situations of extreme high
excretions of oxalate and phosphate and distinguished
between types of nephrons.

from Figure 1? Fluid remains isoosmotic in the early
regions of the nephron. Variations in urine volume do
not reflect differences in the relative dilution of urine in
the ultrafiltrate (as inferred in Fig. 2). Will the use of
these values not affect subsequent calculations as to
where crystals are likely to form?
Author: In Figure 1, the lines represent absolute numbers for volume at specific sites. Figure 2 is drawn for
the sake of experimental design and shows the dilution
at a specific point relative to the 24-hr volume. Four
different values of 24-hr volume were used. The aim of
Figure 2 is to show how much the fluid at a given point
is diluted compared to the end product, the 24-hr urine.
The lines are not related to the ultrafiltrate conditions.
Where relevant, I used the both the lower and upper
ends of ultrafiltrate ranges to calculate which effects
these variations have further on in the nephron. I agree
that much more detail can be put into the model and I
hope that this will be done in the ensuing discussions
you predict.

J.P. Kavanagh: You note that a pH change of 0.03 can
cause an 8-fold change in nucleation lag-time which
might cause one to conclude that in one case, nucleation
might occur in the Loop of Henle, while in another case,
it would not. This emphasizes how critical the choice of
experimental conditions is and, of course, the danger of
trying to extrapolate the in vitro findings to in vivo
interpretations. Can this be done with any confidence?
Author: At the calcium and phosphate concentrations
probably existing at the bend of a short Loop of Henle,
variations around the probable pH-value there, 7.20, are
very critical for HAP-nucleation. At the higher concentrations existing at the bend of a long Loop of Henle and
the higher pH there, 7.4, small variations in pH play no
role for HAP-nucleation and absolutely no role for calcium oxalate nucleation. Thus, it seems safe to extrapolate these findings to the in vivo situation.

W.C. de Bruijn: In the description of the crystallization experiments, urines were used undiluted and 5
times diluted. In Results, you showed in Figure 3 the
results from undiluted urine but failed to show the 5
times diluted and mentioned dilutions from 2 to 50 times
for the DHL and CD parts. Does this mean that beyond
the Loop of Henle, calcium oxalate crystal formation can
be ignored?
Author: I performed experiments with undiluted urines
to show that crystallization proceeds exceedingly slow
under those conditions. I did not include the experiments with 1:5 diluted urines (which have been part of
many previous publications from our group) here, since
they do not contribute to the message. From the model
presented here, it follows that using undiluted urines in
fact is representative for what happens in the bladder.
Should one want to test what happens earlier, in the
Loop of Henle or the collecting ducts, one should apply
the dilutions mentioned in the text. I did not perform
these experiments since it was not the aim of this work.
I also do not conclude that beyond the Loop of Henle no
calcium oxalate nucleation occurs. In fact, calcium oxalate nucleation is likely to occur in the collecting ducts.

C.R. Scheid: The site of nephrocalcin production is not
known with certainty, and local concentrations may
vary. Could you explain bow you get to the statement
that NC levels in the LDLH will be too low to act as an
effective inhibitor of nucleation?
Author: I described in the Data Used section that the
production site of NC bas been suggested to be in the
proximal and/or distal tubule. If NC is produced only
in the distal tubule, the concentration in the Loop of
Henle will be zero. Since I do not know where it is
produced, I assumed the production occurs 50 % in the
proximal tubule and 50 % in the distal tubule. When all
NC would be produced in the proximal tubule, the concentrations in the Loop of Henle would be twice those
mentioned in the text and still below what would be
needed to increase the lag-time from less then 3 seconds
to the needed 100 seconds ( > 95 % reduction of the nucleation rate). Of course, it is also possible that NC is
produced in only a few proximal tubules. This might
bring the NC-concentration into the needed concentration
range. One should also consider the counteractive action
of membranous material deriving from the proximal
tubule.

W.C. de Bruijn: In the Introduction, you narrowed
down stone formation to free particle retention of particles too large to be excreted and fixed particle retention
to the epithelial cell surface coat materials at sites with
poor flow conditions. Do you hold the view that the
step from crystals to stones is a pure intra-tubular crystallization process or that crystal retention (either the
former or the latter) is a prerequisite for stone formation
either interstitially or at papillary sites?

C.R. Scheid: Why does Figure 2 differ so markedly
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Author: The fixed particle mechanism is an interplay
of particle size, interactions between particles and cells
and particle removal. The fixed particle mechanism
may be enhanced by increased sticking of particles due
to particle size, by increased adhesion of particles to
cells (due to different coating of the particles and/or the
cells) and by deficient removal of particles (by shear
forces or actively by the kidney cells).
W.C. de Bruijn: In your proposed nephrolithiasis
model, nephrons are differentiated in a longitudinal
sense. In rat experiments, we found that not all nephrons were responding alike to a generalized chronic (calcium oxalate) challenge (de Water et al., unpublished).
Could you speculate about the chances that in human
stone-formers there is also a lateral differentiation (that
is to say, a complete renculus or even one of the two
kidneys behaves abnormal)?
Author: Central to the model is the notion that local
circumstances play a very important role in stone formation. Local variations in nephron properties, as you
mention, may very well be important in that respect.
Reviewer V: Does Figure 5 show all concentrations of
phosphocitrate at all pH-levels?
Author: No. I did measure them but at low pH-values,
no nucleation occurs within 10 minutes at the high PClevels (5 and 25 µM) and conversely, at pH values
above 7.23, the low concentrations of phosphocitrate
(0.5, 2.5 µM) do not increase the lag-time measurably.
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